Two clusters of serum midkine levels in drug-naive patients with schizophrenia

Neuroscience Letters

Volumn 344, Issue 2, 2003, Pages 95-98

  Shimizu, Eiji ^a   Hashimoto, Kenji ^a   Salama, Ragaa H M ^b   Watanabe, Hiroyuki ^a   Komatsu, Naoya ^a   Okamura, Naoe ^a   Koike, Kaori ^a   Shinoda, Naoyuki ^a   Nakazato, Michiko ^a   Kumakiri, Chikara ^a   Okada, Sin Ichi ^a   Muramatsu, Hisako ^b   Muramatsu, Takashi ^b   Iyo, Masaomi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antipsychotics; Midkine; Neurotrophic factor; Schizophrenia; Serum

Indexed keywords

FIBROBLAST GROWTH FACTOR; MIDKINE; NEUROLEPTIC AGENT;

ADULT; AGED; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; FISHER EXACT TEST; HUMAN; MALE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

EID: 0038018663     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00443-9     Document Type: Review

References (19)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition: 1994;American Psychiatric Press, Washington, DC.
2. Andreasen N.C., Arndt S., Alliger R., Miller D., Flaum M. Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch. Gen. Psychiatry. 52:1995;341-351.
3. Bogerts B. Recent advances in the neuropathology of schizophrenia. Schizophr. Bull. 19:1993;431-445.
4. Haynes L., Rumsby M. The pleiotropin/midkine family of cytokines: role in glial-neuronal signalling. Prog. Brain Res. 132:2001;313-324.
5. Ikematsu S., Yano A., Aridome K., Kikuchi M., Kumai H., Nagano H., Okamoto K., Oda M., Sakuma S., Aikou T., Muramatsu H., Kadomatsu K., Muramatsu T. Serum midkine levels are increased in patients with various types of carcinomas. Br. J. Cancer. 83:2000;701-706.
6. Kato S., Shinozawa T., Takikawa M., Kato M., Hirano A., Awaya A., Ohama E. Midkine, a new neurotrophic factor, is present in glial cytoplasmic inclusions of multiple system atrophy brains. Acta Neuropathol. (Berl.). 100:2000;481-489.
7. Kronfol Z., Remick D.G. Cytokines and the brain: implications for clinical psychiatry. Am. J. Psychiatry. 157:2000;683-694.
8. Matsumoto K., Wanaka A., Takatsuji K., Muramatsu H., Muramatsu T., Tohyama M. A novel family of heparin-binding growth factors, pleiotrophin and midkine, is expressed in the developing rat cerebral cortex. Brain Res. Dev. Brain Res. 79:1994;229-241.
9. Mishima K., Asai A., Kadomatsu K., Ino Y., Nomura K., Narita Y., Muramatsu T., Kirino T. Increased expression of midkine during the progression of human astrocytomas. Neurosci. Lett. 233:1997;29-32.
10. Mochizuki R., Takeda A., Sato N., Kimpara T., Onodera H., Itoyama Y., Muramatsu T. Induction of midkine expression in reactive astrocytes following rat transient forebrain ischemia. Exp. Neurol. 149:1998;73-78.
11. Muramatsu H., Shirahama H., Yonezawa S., Maruta H., Muramatsu T. Midkine, a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution. Dev. Biol. 159:1993;392-402.
12. Muramatsu H., Song X.J., Koide N., Hada H., Tsuji T., Kadomatsu K., Inui T., Kimura T., Sakakibara S., Muramatsu T. Enzyme-linked immunoassay for midkine, and its application to evaluation of midkine levels in developing mouse brain and sera from patients with hepatocellular carcinomas. J. Biochem. (Tokyo). 119:1996;1171-1175.
13. Muramatsu T. Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J. Biochem. (Tokyo). 132:2002;359-371.
14. Murray R.M., O'Callaghan E., Castle D.J., Lewis S.W. A neurodevelopmental approach to the classification of schizophrenia. Schizophr. Res. 18:1992;319-332.
15. Nakamoto M., Matsubara S., Miyauchi T., Obama H., Ozawa M., Muramatsu T. A new family of heparin binding growth/differentiation factors: differential expression of the midkine (MK) and HB-GAM genes during mouse development, J. Biochem. (Tokyo). 112:1992;346-349.
16. Nakamura E., Kadomatsu K., Yuasa S., Muramatsu H., Mamiya T., Nabeshima T., Fan Q.W., Ishiguro K., Igakura T., Matsubara S., Kaname T., Horiba M., Saito H., Muramatsu T. Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour. Genes Cells. 3:1998;811-822.
17. Overall J.E., Gorham D.R. The Brief Psychiatric Rating Scale. Psychol. Rep. 10:1962;799-812.
18. Wada M., Kamata M., Aizu Y., Morita T., Hu J., Oyanagi K. Alteration of midkine expression in the ischemic brain of humans. J. Neurol. Sci. 200:2002;67-73.
19. Yasuhara O., Muramatsu H., Kim S.U., Muramatsu T., Maruta H., McGeer P.L. Midkine, a novel neurotrophic factor, is present in senile plaques of Alzheimer disease. Biochem. Biophys. Res. Commun. 192:1993;246-251.